How the osteoclast degrades bone - PubMed (original) (raw)

Review

How the osteoclast degrades bone

H C Blair. Bioessays. 1998 Oct.

Abstract

Osteoclasts are multinucleated monocyte-macrophage derivatives that degrade bone. Their specialized role is central to a process that continuously removes and replaces segments of the skeleton in the higher vertebrates. Osteoclasts allow skeletal mineral to be used to manage extracellular calcium activity, which is an important adaptation for life on land, and solid skeletal structure to be replaced by hollow architecture that has a superior strength-to-weight ratio. Degrading bone also allows periodic repair and remodeling for ordered growth and efficient response to mechanical loads. A fairly comprehensive view of osteoclastic ontogeny and function is emerging from recent studies. Osteoclasts dissolve bone mineral by massive acid secretion and secrete specialized proteinases that degrade the organic matrix, mainly type I collagen, in this acidic milieu. The site of bone dissolution is a high-calcium environment; removal of degradation products by transcytosis of membrane vesicles allows the osteoclast to maintain a normal intracellular calcium. Osteoclastic differentiation is normally balanced with bone formation, although bone formation is the function of unrelated stromal cell-derived osteoblasts. Interactions between osteoclast precursors and bone-forming cells are believed to control osteoclast differentiation under most circumstances, preserving bone architecture over many cycles of bone replacement.

PubMed Disclaimer

Cited by

Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification.
Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM. Steitz SA, et al. Am J Pathol. 2002 Dec;161(6):2035-46. doi: 10.1016/S0002-9440(10)64482-3. Am J Pathol. 2002. PMID: 12466120 Free PMC article.
Advances in osteoclast biology: old findings and new insights from mouse models.
Edwards JR, Mundy GR. Edwards JR, et al. Nat Rev Rheumatol. 2011 Apr;7(4):235-43. doi: 10.1038/nrrheum.2011.23. Epub 2011 Mar 8. Nat Rev Rheumatol. 2011. PMID: 21386794 Review.
Extracellular Release of Citrullinated Vimentin Directly Acts on Osteoclasts to Promote Bone Resorption in a Mouse Model of Periodontitis.
Shindo S, Pierrelus R, Ikeda A, Nakamura S, Heidari A, Pastore MR, Leon E, Ruiz S, Chheda H, Khatiwala R, Kumagai T, Tolson G, Elderbashy I, Ouhara K, Han X, Hernandez M, Vardar-Sengul S, Shiba H, Kawai T. Shindo S, et al. Cells. 2023 Apr 8;12(8):1109. doi: 10.3390/cells12081109. Cells. 2023. PMID: 37190018 Free PMC article.
Secretion of L-glutamate from osteoclasts through transcytosis.
Morimoto R, Uehara S, Yatsushiro S, Juge N, Hua Z, Senoh S, Echigo N, Hayashi M, Mizoguchi T, Ninomiya T, Udagawa N, Omote H, Yamamoto A, Edwards RH, Moriyama Y. Morimoto R, et al. EMBO J. 2006 Sep 20;25(18):4175-86. doi: 10.1038/sj.emboj.7601317. Epub 2006 Sep 7. EMBO J. 2006. PMID: 16957773 Free PMC article.
Exploring the impact of naltrexone on the THBS1/eNOS/NO pathway in osteoporotic bile duct-ligated rats.
Hosseini-Fard SR, Etemad-Moghadam S, Alaeddini M, Dehpour AR, Emamgholipour S, Golestani A. Hosseini-Fard SR, et al. Sci Rep. 2024 Jan 2;14(1):48. doi: 10.1038/s41598-023-50547-w. Sci Rep. 2024. PMID: 38167957 Free PMC article.

How the osteoclast degrades bone - PubMed (original) (raw)